​

Eledon Pharmaceuticals (ELDN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

ELDN Stock Forecast

Eledon Pharmaceuticals (ELDN) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $9.00, with a high of $9.00 and a low of $9.00. This represents a 496.03% increase from the last price of $1.51.

$1 $2 $3 $4 $5 $6 $7 $8 $9 High: $9 Avg: $9 Low: $9 Last Closed Price: $1.51

ELDN Stock Rating

Eledon Pharmaceuticals stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

ELDN Price Target Upside V Benchmarks

TypeNameUpside
StockEledon Pharmaceuticals496.03%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$9.00
Last Closing Price$1.51$1.51$1.51
Upside/Downside--496.03%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25-7---7
Nov, 2516---7
Oct, 2516---7
Sep, 2516---7
Aug, 2516---7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 18, 2025Yi ChenH.C. Wainwright$9.00$2.78223.74%496.03%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 07, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$-0.73----
Avg Forecast$-1.70$-0.71$-1.08$-1.09$-1.04$-0.92
High Forecast$-1.65$-0.29$-0.81$-0.94$-1.01$-0.92
Low Forecast$-1.79$-1.51$-1.37$-1.24$-1.07$-0.92
Surprise %-2.82%----

Revenue Forecast

$15M $22M $29M $36M $43M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$50.00M--$17.40M
High Forecast--$50.00M--$17.40M
Low Forecast--$50.00M--$17.40M
Surprise %------

Net Income Forecast

$-45M $-37M $-29M $-21M $-13M $-5M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-40.33M$-35.32M----
Avg Forecast$-42.40M$-24.55M$-26.79M$-26.83M$-25.60M$-22.65M
High Forecast$-40.64M$-7.18M$-19.96M$-23.04M$-24.84M$-22.65M
Low Forecast$-44.16M$-37.28M$-33.62M$-30.63M$-26.36M$-22.65M
Surprise %-4.89%43.89%----

ELDN Forecast FAQ

Is Eledon Pharmaceuticals stock a buy?

Eledon Pharmaceuticals stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Eledon Pharmaceuticals is a favorable investment for most analysts.

What is Eledon Pharmaceuticals's price target?

Eledon Pharmaceuticals's price target, set by 4 Wall Street analysts, averages $9 over the next 12 months. The price target range spans from $9 at the low end to $9 at the high end, suggesting a potential 496.03% change from the previous closing price of $1.51.

How does Eledon Pharmaceuticals stock forecast compare to its benchmarks?

Eledon Pharmaceuticals's stock forecast shows a 496.03% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Eledon Pharmaceuticals over the past three months?

  • December 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Eledon Pharmaceuticals’s EPS forecast?

Eledon Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.08, marking a 47.95% increase from the reported $-0.73 in 2024. Estimates for the following years are $-1.09 in 2026, $-1.04 in 2027, and $-0.92 in 2028.

What is Eledon Pharmaceuticals’s revenue forecast?

Eledon Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $50M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, followed by $0 for 2027, and $17.4M for 2028.

What is Eledon Pharmaceuticals’s net income forecast?

Eledon Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $-26.79M, representing a -24.16% decrease from the reported $-35.322M in 2024. Projections indicate $-26.835M in 2026, $-25.604M in 2027, and $-22.65M in 2028.